From MDS to AML: Understanding the Pathology, Diagnostics, and Genetic Relationship 10/10/17

From MDS to AML: What Every Patient Needs to Know 11/28/17Подробнее

Use of Molecular Genetic Testing in MDS and MPNПодробнее

Myelodysplastic Syndrome (MDS) - a precursor to Acute Myeloid Leukemia (AML) ?! - Hematology SeriesПодробнее

Advancing the management of MDS and AML: Novel immune-based approachesПодробнее

Clinical Implications of Genetic Mutations in Myelodysplastic SyndromesПодробнее

Genetic Basis of MDSПодробнее

Myelodysplastic syndromes - causes, symptoms, diagnosis, treatment, pathologyПодробнее

Understanding AMLПодробнее

Molecular Underpinnings of Myeloid Malignancies (2018)Подробнее

Molecular Profiling of Myelodysplastic SyndromesПодробнее

Genomics: MDS pathology & treatmentПодробнее

TP53-Mutant AML: A Pathology-Guided Journey Through Diagnostic PrinciplesПодробнее

Venetoclax with decitabine for high-risk AML and MDSПодробнее

Key AML Testing for Better Care: Understanding Prognosis and Treatment ChoicesПодробнее

Highlights of ASH 2016: MDS 2/7/17Подробнее

Precision Medicine in MDS and AMLПодробнее

My approach to MDS managementПодробнее

Role of immune system in MDS pathogenesisПодробнее